APA (7th ed.) Citation

Xu, S., Qiu, L., Xu, L., Liu, Y., & Zhang, J. (2024). Development and validation of a nomogram for assessing hepatocellular carcinoma risk after SVR in hepatitis C patients with advanced fibrosis and cirrhosis. Infectious Agents & Cancer, 19(1), 1. https://doi.org/10.1186/s13027-024-00578-3

Chicago Style (17th ed.) Citation

Xu, Shanshan, Lixia Qiu, Liang Xu, Yali Liu, and Jing Zhang. "Development and Validation of a Nomogram for Assessing Hepatocellular Carcinoma Risk After SVR in Hepatitis C Patients with Advanced Fibrosis and Cirrhosis." Infectious Agents & Cancer 19, no. 1 (2024): 1. https://doi.org/10.1186/s13027-024-00578-3.

MLA (9th ed.) Citation

Xu, Shanshan, et al. "Development and Validation of a Nomogram for Assessing Hepatocellular Carcinoma Risk After SVR in Hepatitis C Patients with Advanced Fibrosis and Cirrhosis." Infectious Agents & Cancer, vol. 19, no. 1, 2024, p. 1, https://doi.org/10.1186/s13027-024-00578-3.